Alopecia areata.

@article{Gilhar2012AlopeciaA,
  title={Alopecia areata.},
  author={Amos Gilhar and Amos Etzioni and Ralf Paus},
  journal={The New England journal of medicine},
  year={2012},
  volume={366 16},
  pages={
          1515-25
        },
  url={https://api.semanticscholar.org/CorpusID:5201399}
}
From Flieman Hospital, B.G., A.E., and Meyer’s Children’'s Hospital, Rambam Campus, Haifa, Israel; the Department of Dermatology, University of Lubeck, Lubek, Germany; and the School of Translational Medicine,University of Manchester, Manchester, United Kingdom.
View on PubMed
baldgirlsdolunch.org
177 Citations
Highly Influential Citations
9
Background Citations
49
Results Citations
2

Figures and Tables from this paper

177 Citations

Alopecia Areata: An Update on Treatment Options for Children

The data on therapy for alopecia areata in pediatric patients is reviewed and topical therapies consisting of topical steroids and topical irritating compounds/contact sensitizers are used.

Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management

The recent advances in the pathogenesis, diagnosis, and treatment of AA are discussed, including antihistamines, platelet-rich plasma (PRP) injection, and other novel therapies have been well explored.

Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata

Given the diverse treatment options and the varying psychological impacts on AA patients, the most appropriate personalized treatment plan should be established through shared decision making between physicians and patients.

Alopecia Areata: An Autoimmune Disease of Multiple Players

Current evidence that emphasizes molecular mechanisms, possible causative etiologies, and targeted immunotherapies for AA is gathered to shed light on new strategies to effectively manage AA.

Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)

Several therapeutic options in the AA include the injection of corticosteroids, minoxidil, immunotherapies, photochemotherapy, calcineurin inhibitors, metrotrexate, sulfasalazzine, azatioprine, laser therapy, PRP therapy, and therapy with stem cells.

Alopecia Areata: An Update

Clinical presentation varies from small alopecia patches most commonly on the scalp to full body involvement, and characteristic “swarm of bees” appearance on histopathology is confirmatory in acute cases.

Clinico-Dermoscopic Pattern of Beard Alopecia Areata: A Cross-Sectional Study

Trichoscopy of BAA may reveal newer nonfollicular findings, in addition to the follicular findings already described in literature for AA.

The Incidence of Alopecia Areata in a COVID-19-Vaccinated Population: A Single-Center Review

This investigation noted no apparent increase in the incidence of alopecia areata among the vaccinated population compared to the unvaccinated population.

Alopecia Areata is Associated with Atopic Diathesis; Results from a Population-Based Study of 51,561 Patients.

Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report

The mechanisms and economic benefits of various JAK inhibitors in the treatment of AA are investigated to provide better guidance to patients with recurring disease who need long-term medication, and to their doctors in choosing a more rational therapeutic agent according to the patient’s condition and economic status.
...

92 References

Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?

It is important for clinicians and pathologists to recognize the different phases of AA, so that in the absence of the classic findings of a peribulbar lymphocytic infiltrate, a diagnosis of AA can still confidently be made.

Management of alopecia areata

Alopecia areata is a common condition characterised by sudden onset of patchy hair loss without signs of skin inflammation or scarring, and is a psychologically distressing disease and doctors should provide patients with realistic advice about treatments and their effectiveness.

Alopecia areata prevalence by gender and age

The authors describe the use of a non-ablative fractional resurfacing device utilized prior to the application of their photosensitizer to enhance the absorption of aminolevulinic acid into the skin.

Interventions for alopecia areata.

No RCTs were found on the use of diphencyprone, dinitrochlorobenzene, intralesional corticosteroids or dithranol although they are commonly used for the treatment of alopecia areata.

Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey.

The prevalence of AA is presented as estimated from the findings of NHANES-I, a dermatologic examination of 20 749 individuals in a probability sample of the US population conducted from 1971 through 1974.

Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis.

The Epidemiology of Childhood Alopecia Areata in China: A Study of 226 Patients

The earlier the age of onset, the greater the severity of the disease and the effect of genetic factors is important in the occurrence of this disease.

Topical minoxidil in the treatment of alopecia areata and male-pattern alopecia.

A 1% minoxidil topical preparation in a cream base was used in 28 cases of alopecia areata (AA) and 40 cases of male-pattern alopeca (MPA) and the efficacy was determined using the criteria of Weiss et al, 1 and the involution of Hamilton's criteria for classification 5 in MPA.

Alopecia areata: evidence-based treatments.

Alopecia areata update: part II. Treatment.

...

Related Papers

Showing 1 through 3 of 0 Related Papers